Subscribe free

HPB & Spleen ·

New guidelines aim to improve outcomes for HCC patients

A consensus from Chinese experts has established eight recommendations for diagnosing and treating hepatocellular carcinoma (HCC) with microvascular invasion (MVI). These guidelines emphasize the use of MVI grading criteria and the EH-BH nomogram for improved accuracy in prediction and management. The goal is to enhance recurrence-free survival and overall survival rates among HCC patients facing MVI, addressing significant gaps in current knowledge and practice surrounding this critical aspect of HCC treatment.

Review by Sun J, Xia Y, Shen F and Cheng S in Hepatobiliary Surg Nutr

Copyright © 2025 AME Publishing Company. All rights reserved.

read the whole article in Hepatobiliary Surg Nutr

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Br J Surg5 Nov 2026

Rectal cancer and liver spread: similar outcomes

Removing the rectal tumor and liver spread in one operation did not clearly raise complications or hurt survival compared with two separate operations, a French national study found.

All papers in HPB & Spleen →